STANDARD BIOTOOLS INC. — Director's Dealing 2012

Dec 11, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2012-12-07

Reporting Person: JONES ROBERT C (EVP, RESEARCH & DEVELOPMENT)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-07	Common Stock	M	3060	$3.3908	Acquired	3060	Direct
2012-12-07	Common Stock	S	3060	$13.5022	Disposed	0	Direct
2012-12-07	Common Stock	M	1156	$4.0828	Acquired	1156	Direct
2012-12-07	Common Stock	S	1156	$13.5022	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-07	Employee Stock Option (Right to Buy)	$3.3908	M	3060	Disposed	2015-08-02	Common Stock (3060)	Direct
2012-12-07	Employee Stock Option (Right to Buy)	$4.0828	M	1156	Disposed	2019-11-17	Common Stock (1156)	Direct

Footnotes

F1: The sales reported by Mr. Jones were effected pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2012.

F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $13.43 to $13.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3: The shares subject to the Option fully vested on August 1, 2009.

F4: 61% of the shares subject to the Option vested on December 31, 2009, 25% of the remaining 39% of the shares subject to the Option vested on April 1, 2010 and 1/48th of the remaining 39% of the shares subject to the Option shall vest each month thereafter such that all shares subject to the Option shall be fully vested on April 1, 2013.